CPIXNasdaq United States
Market cap
$116.868 M
$7.80 +1.56%
Close of 7 Aug 2026
Revenue
$44.5M
#2781 by revenue
Earnings
-$2.84M
Loss-making
Shares outstanding
14,983,107
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cumberland Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.